Andrew Farquharson - Net Worth and Insider Trading
Andrew Farquharson Net Worth
The estimated net worth of Andrew Farquharson is at least $352,829 dollars as of 2024-11-13. Andrew Farquharson is the Director of Rani Therapeutics Holdings Inc and owns about 139,458 shares of Rani Therapeutics Holdings Inc (RANI) stock worth over $352,829. Details can be seen in Andrew Farquharson's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Andrew Farquharson has not made any transactions after 2022-08-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Andrew Farquharson
Andrew Farquharson Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Andrew Farquharson owns 1 companies in total, including Rani Therapeutics Holdings Inc (RANI) .
Click here to see the complete history of Andrew Farquharson’s form 4 insider trades.
Insider Ownership Summary of Andrew Farquharson
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RANI | Rani Therapeutics Holdings Inc | 2022-08-17 | director |
Andrew Farquharson Latest Holdings Summary
Andrew Farquharson currently owns a total of 1 stock. Andrew Farquharson owns 139,458 shares of Rani Therapeutics Holdings Inc (RANI) as of August 17, 2022, with a value of $352,829.
Latest Holdings of Andrew Farquharson
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RANI | Rani Therapeutics Holdings Inc | 2022-08-17 | 139,458 | 2.53 | 352,829 |
Holding Weightings of Andrew Farquharson
Andrew Farquharson Form 4 Trading Tracker
According to the SEC Form 4 filings, Andrew Farquharson has made a total of 1 transactions in Rani Therapeutics Holdings Inc (RANI) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Rani Therapeutics Holdings Inc is the sale of 80,252 shares on August 17, 2022, which brought Andrew Farquharson around $853,881.
Insider Trading History of Andrew Farquharson
- 1
Andrew Farquharson Trading Performance
Andrew Farquharson Ownership Network
Ownership Network List of Andrew Farquharson
Ownership Network Relation of Andrew Farquharson
Andrew Farquharson Owned Company Details
What does Rani Therapeutics Holdings Inc do?
Who are the key executives at Rani Therapeutics Holdings Inc?
Andrew Farquharson is the director of Rani Therapeutics Holdings Inc. Other key executives at Rani Therapeutics Holdings Inc include 10 percent owner South Cone Investments Limited Partnership , director & CEO Talat Imran , and 10 percent owner Quiroga Cortes Isidoro Alfonso .
Rani Therapeutics Holdings Inc (RANI) Insider Trades Summary
Over the past 18 months, Andrew Farquharson made no insider transaction in Rani Therapeutics Holdings Inc (RANI). Other recent insider transactions involving Rani Therapeutics Holdings Inc (RANI) include a net purchase of 40,000 shares made by Talat Imran , a net purchase of 1,435,805 shares made by South Cone Investments Limited Partnership , and a net sale of 5,265,165 shares made by Quiroga Cortes Isidoro Alfonso .
In summary, during the past 3 months, insiders sold 3,829,360 shares of Rani Therapeutics Holdings Inc (RANI) in total and bought 0 shares, with a net sale of 3,829,360 shares. During the past 18 months, 9,094,525 shares of Rani Therapeutics Holdings Inc (RANI) were sold and 5,356,165 shares were bought by its insiders, resulting in a net sale of 3,738,360 shares.
Rani Therapeutics Holdings Inc (RANI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Rani Therapeutics Holdings Inc Insider Transactions
Andrew Farquharson Mailing Address
Above is the net worth, insider trading, and ownership report for Andrew Farquharson. You might contact Andrew Farquharson via mailing address: C/o Rani Therapeutics Holdings, Inc., 2051 Ringwood Avenue, San Jose Ca 95131.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
